Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Treatment success
RCT	220 people with HIV and oropharyngeal candidiasis In review	Proportion of people with clinical cure 14 days 105/110 (95%) with fluconazole 150 mg daily for 14 days 105/110 (95%) with fluconazole 750 mg single dose	RR 1.00 95% CI 0.94 to 1.06		Not significant
RCT	220 people with HIV and oropharyngeal candidiasis In review	Proportion of people relapsing 42 days 12/100 (12.0%) with fluconazole 150 mg daily for 14 days 12/94 (12.8%) with fluconazole 750 mg single dose	RR 0.94 95% CI 0.44 to 1.99		Not significant
Systematic review	56 people Data from 1 RCT	Proportion of people with clinical cure 28 days 26/28 (93%) with fluconazole 50 mg daily for 7 days 21/28 (75%) with fluconazole 150 mg single dose	RR 1.24 95% CI 0.98 to 1.52		Not significant